EE200200656A - Ravis kasutatavad tropaani derivaadid - Google Patents

Ravis kasutatavad tropaani derivaadid

Info

Publication number: EE200200656A
Authority: EE; Estonia
Prior art keywords: therapeutic use; tropane derivatives; tropane; derivatives; therapeutic
Prior art date: 2000-05-26

Application number

EEP200200656A

Other languages

English (en)

Inventor

Perros Manoussos

Anthony Price David

Luzia Christa Stammen Blanda

Wood Anthony

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-26

Filing date

2001-05-09

Publication date

2004-06-15

2000-05-26 Priority claimed from GB0014046A external-priority patent/GB0014046D0/en

2000-06-27 Priority claimed from GB0015835A external-priority patent/GB0015835D0/en

2001-05-09 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2004-06-15 Publication of EE200200656A publication Critical patent/EE200200656A/et

2008-12-15 Publication of EE05110B1 publication Critical patent/EE05110B1/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Oncology (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
AIDS & HIV (AREA)
Psychiatry (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
Tropical Medicine & Parasitology (AREA)

EEP200200656A 2000-05-26 2001-05-09 3-(3-isopropl-5-metl-4H-1,2,4-triasool-4-l)ekso-8-asabitsklo[3.2.1]oktaani derivaadid, selliste derivaatide valmistamismeetodid, nende valmistamisel kasutatavad vahehendid, selliseid derivaatesisaldavad kompositsioonid ja kombinatsioonid ning EE05110B1 (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0014046A GB0014046D0 (en)	2000-05-26	2000-05-26	Compounds useful in therapy
GB0015835A GB0015835D0 (en)	2000-06-27	2000-06-27	Compounds useful in therapy
PCT/IB2001/000806 WO2001090106A2 (en)	2000-05-26	2001-05-09	Tryasolyl tropane derivatives as ccr5 modulators

Publications (2)

Publication Number	Publication Date
EE200200656A true EE200200656A (et)	2004-06-15
EE05110B1 EE05110B1 (et)	2008-12-15

Family

ID=26244452

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200656A EE05110B1 (et)	2000-05-26	2001-05-09	3-(3-isopropl-5-metl-4H-1,2,4-triasool-4-l)ekso-8-asabitsklo[3.2.1]oktaani derivaadid, selliste derivaatide valmistamismeetodid, nende valmistamisel kasutatavad vahehendid, selliseid derivaatesisaldavad kompositsioonid ja kombinatsioonid ning

Country Status (51)

Country	Link
EP (3)	EP1990341B1 (et)
JP (2)	JP3693957B2 (et)
KR (2)	KR100523501B1 (et)
CN (2)	CN100355753C (et)
AP (1)	AP1965A (et)
AR (2)	AR028622A1 (et)
AT (2)	ATE407134T1 (et)
AU (2)	AU2001252482B2 (et)
BG (1)	BG65966B1 (et)
BR (1)	BRPI0110955B8 (et)
CA (1)	CA2408909C (et)
CR (1)	CR10145A (et)
CU (1)	CU23288B7 (et)
CY (3)	CY2008006I1 (et)
CZ (1)	CZ299102B6 (et)
DE (3)	DE122008000011I1 (et)
DK (2)	DK1284974T3 (et)
DZ (1)	DZ3464A1 (et)
EA (2)	EA007580B1 (et)
EE (1)	EE05110B1 (et)
EG (1)	EG24137A (et)
ES (3)	ES2215129T3 (et)
FR (1)	FR08C0007I2 (et)
GE (1)	GEP20063799B (et)
HK (3)	HK1054927A1 (et)
HR (1)	HRP20020938B1 (et)
HU (1)	HU225810B1 (et)
IL (2)	IL152531A0 (et)
IS (1)	IS2511B (et)
LT (1)	LTC1284974I2 (et)
LU (1)	LU91417I2 (et)
MA (1)	MA26902A1 (et)
ME (1)	ME00555B (et)
MX (1)	MXPA02011631A (et)
MY (3)	MY131019A (et)
NL (1)	NL300338I2 (et)
NO (3)	NO327892B1 (et)
NZ (1)	NZ521477A (et)
OA (1)	OA12264A (et)
PA (1)	PA8517101A1 (et)
PE (1)	PE20011371A1 (et)
PL (1)	PL200551B1 (et)
PT (2)	PT1526134E (et)
RS (2)	RS50904B (et)
SI (2)	SI1526134T1 (et)
SK (1)	SK286129B6 (et)
TN (1)	TNSN01077A1 (et)
TR (1)	TR200400541T4 (et)
TW (1)	TWI230160B (et)
UY (1)	UY26727A1 (et)
WO (1)	WO2001090106A2 (et)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE122008000011I1 (de) *	2000-05-26	2008-06-05	Pfizer	Triazolyltropanderivate als ccr5-modulatoren
CN1547575A (zh) *	2001-06-12	2004-11-17	Sk��ʽ��	新颖苯基烷基二胺和酰胺类似物
SE0200919D0 (sv) *	2002-03-25	2002-03-25	Astrazeneca Ab	Chemical compounds
US6855724B2 (en)	2002-04-08	2005-02-15	Agouron Pharmaceuticals, Inc.	Tropane derivatives useful in therapy
GB0208071D0 (en) *	2002-04-08	2002-05-22	Pfizer Ltd	Tropane derivatives useful in therapy
PT1492789E (pt) *	2002-04-08	2006-09-29	Pfizer	Derivados de tropano como moduladores ccr5
AU2003230129A1 (en) *	2002-05-23	2003-12-12	Pfizer Inc.	Method for identification of a ligand whereby receptor residence time is measured
ES2311755T3 (es)	2002-12-13	2009-02-16	Smithkline Beecham Corporation	Compuestos de ciclohexilo como antagonistas de ccrs.
DE10336274A1 (de) *	2003-08-07	2005-03-10	Honeywell Specialty Chemicals	Verfahren zur Herstellung von geminalen Difluoralkanen
RU2387646C2 (ru)	2003-08-29	2010-04-27	Рэнбакси Лабораториз Лимитед	Ингибиторы фосфодиэстеразы типа-iv
CA2579609A1 (en)	2003-09-10	2005-03-17	Virochem Pharma Inc.	Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
PT1682545E (pt) *	2003-10-03	2008-02-11	Pfizer	Derivados de tropano substituídos com imidazopiridina com actividade antagonista do receptor ccr5, para o tratamento do hiv e da inflamação
TW200610761A (en)	2004-04-23	2006-04-01	Astrazeneca Ab	Chemical compounds
AU2005251891A1 (en)	2004-06-09	2005-12-22	F. Hoffmann-La Roche Ag	Octahydro-pyrrolo[3,4-C] derivatives and their use as antiviral compounds
WO2006055660A2 (en) *	2004-11-19	2006-05-26	Boehringer Ingelheim International Gmbh	Method for treating hiv infection through co-administration of tipranavir and uk-427, 857
WO2006064340A2 (en) *	2004-12-13	2006-06-22	Pfizer Limited	Process for the preparation of n-acyl beta-aminoaldehydes
US7665658B2 (en)	2005-06-07	2010-02-23	First Data Corporation	Dynamic aggregation of payment transactions
US20070026441A1 (en)	2005-07-22	2007-02-01	Olson William C	Methods for reducing viral load in HIV-1-infected patients
BRPI0617720A2 (pt)	2005-10-19	2011-08-02	Hoffmann La Roche	compostos inibidores de nnrt de fenil-acetamida, usos dos referidos compostos e composição farmacêutica que os contém
CN101501002B (zh)	2006-08-16	2012-06-27	弗·哈夫曼-拉罗切有限公司	非核苷逆转录酶抑制剂
WO2008063600A2 (en) *	2006-11-17	2008-05-29	Concert Pharmaceuticals Inc.	Triazolyl tropane derivatives
WO2008071587A2 (en)	2006-12-13	2008-06-19	F. Hoffmann-La Roche Ag	2-(piperidin-4-yl)-4-phenoxy- or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
US20080146605A1 (en) *	2006-12-19	2008-06-19	Auspex Pharmaceuticals, Inc.	Preparation and utility of ccr5 inhibitors
US20080207659A1 (en)	2007-02-15	2008-08-28	Asit Kumar Chakraborti	Inhibitors of phosphodiesterase type 4
WO2008132128A2 (en) *	2007-04-27	2008-11-06	Solvay (Société Anonyme)	Synthesis of a pharmaceutically active compound
AU2009220462A1 (en) *	2008-02-29	2009-09-11	Merck Sharp & Dohme Corp.	CCR5 antagonists as prophylactics for preventing HIV infection and methods of inhibiting transmission of same
CN101712679B (zh) *	2008-10-08	2013-04-10	中国科学院上海药物研究所	一种酰胺类化合物、其药物组合物及其制备方法和用途
ES2564457T3 (es) *	2009-07-24	2016-03-22	Glaxosmithkline Llc	Derivados de azabiciclo[3,2,1]octilo para su uso en el tratamiento de VIH
CN102140104B (zh) *	2010-02-03	2014-11-12	中国科学院上海药物研究所	1-(3-(s)-氨基丙基)-哌啶-4-氨基酰胺类化合物、其药物组合物及其制备方法和用途
BR112012024522A2 (pt)	2010-04-02	2017-08-08	Phivco 1 Llc	combinação, uso de uma combinação, composição farmacêutica, forma de dosagem única , kit, e, método para tratar um distúrbio
CN103159754A (zh) *	2011-12-19	2013-06-19	中国科学院上海药物研究所	一种氨基丙基取代托烷胺类化合物、其药物组合物及其制备方法和用途
AU2013340559B2 (en)	2012-10-29	2018-03-15	Cipla Limited	Antiviral phosphonate analogues and process for preparation thereof
CZ306455B6 (cs)	2013-04-26	2017-02-01	Zentiva, K.S.	Nový způsob syntézy Maravirocu
CN103497164B (zh) *	2013-09-23	2015-12-23	西安近代化学研究所	一种蒽衍生物及其制备方法
CN104304248B (zh) *	2014-10-23	2016-08-10	西北农林科技大学	3-芳基丙酸酯类化合物作为制备杀螨药物的应用
CN104402883B (zh) *	2014-10-24	2016-04-27	艾琪康医药科技（上海）有限公司	4，4-二氟金刚烷甲酰胺衍生物、药物组合物及其制备方法和用途
CN104387379B (zh) *	2014-11-26	2017-01-11	扬州氟药科技有限公司	一种二氟亚甲基哌啶甲酰胺衍生物及其制备方法和用途
CN104860946A (zh) *	2015-05-14	2015-08-26	湖北生物医药产业技术研究院有限公司	Ccr5拮抗剂的制备方法
CN107879963A (zh) *	2016-09-29	2018-04-06	中国科学院上海药物研究所	新型手性配体、金属螯合物、多种非天然氨基酸、马拉维诺及其关键中间体的合成方法
US11629196B2 (en)	2020-04-27	2023-04-18	Incelldx, Inc.	Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5648511A (en) *	1990-11-19	1997-07-15	G.D. Searle & Co.	Method for making intermediates useful in the synthesis of retroviral protease inhibitors
FR2676444B1 (fr) *	1991-05-16	1995-03-10	Sanofi Elf	Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
GB9310713D0 (en) *	1993-05-24	1993-07-07	Zeneca Ltd	Aryl substituted heterocycles
KR100210417B1 (ko) *	1994-04-19	1999-07-15	페더 벨링	신경전달물질 재흡수 억제제인 트로판-2-알독심 유도체
GB9523526D0 (en) *	1995-11-17	1996-01-17	Zeneca Ltd	Therapeutic compounds
DE19546462A1 (de) *	1995-12-13	1997-06-19	Bayer Ag	Diarylacetylenketone
AU1208397A (en) *	1995-12-28	1997-07-28	Takeda Chemical Industries Ltd.	Diphenylmethane derivatives as mip-1alpha/rantes receptor antagonists
US6323206B1 (en) *	1996-07-12	2001-11-27	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
WO1998002151A2 (en) *	1996-07-12	1998-01-22	Leukosite, Inc.	Chemokine receptor antagonists and methods of use therefor
AU5604998A (en) *	1996-12-13	1998-07-03	Merck & Co., Inc.	Spiro-substituted azacycles as modulators of chemokine receptor activity
AU5522498A (en) *	1996-12-13	1998-07-03	Merck & Co., Inc.	Substituted aryl piperazines as modulators of chemokine receptor activity
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
WO1999004794A1 (en) *	1997-07-25	1999-02-04	Merck & Co., Inc.	Cyclic amine modulators of chemokine receptor activity
IL125658A0 (en) *	1997-08-18	1999-04-11	Hoffmann La Roche	Ccr-3 receptor antagonists
AR013669A1 (es) *	1997-10-07	2001-01-10	Smithkline Beecham Corp	Compuestos y metodos
US6433165B1 (en) *	1998-01-21	2002-08-13	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
EP1013276A1 (en)	1998-12-23	2000-06-28	Pfizer Inc.	Aminoazacycloalkanes as CCR5 modulators
US7217714B1 (en) *	1998-12-23	2007-05-15	Agouron Pharmaceuticals, Inc.	CCR5 modulators
PE20001420A1 (es) *	1998-12-23	2000-12-18	Pfizer	Moduladores de ccr5
DE122008000011I1 (de) *	2000-05-26	2008-06-05	Pfizer	Triazolyltropanderivate als ccr5-modulatoren

2001
- 2001-05-09 DE DE200812000011 patent/DE122008000011I1/de active Pending
- 2001-05-09 PT PT04004193T patent/PT1526134E/pt unknown
- 2001-05-09 CN CNB2005100068151A patent/CN100355753C/zh not_active Expired - Lifetime
- 2001-05-09 CA CA 2408909 patent/CA2408909C/en not_active Expired - Lifetime
- 2001-05-09 AT AT04004193T patent/ATE407134T1/de active
- 2001-05-09 RS YUP82202 patent/RS50904B/sr unknown
- 2001-05-09 ES ES01925808T patent/ES2215129T3/es not_active Expired - Lifetime
- 2001-05-09 DE DE2001602233 patent/DE60102233T2/de not_active Expired - Lifetime
- 2001-05-09 SK SK1643-2002A patent/SK286129B6/sk active Protection Beyond IP Right Term
- 2001-05-09 TR TR200400541T patent/TR200400541T4/xx unknown
- 2001-05-09 SI SI200130862T patent/SI1526134T1/sl unknown
- 2001-05-09 RS RSP-2009/0438A patent/RS51436B/en unknown
- 2001-05-09 AU AU2001252482A patent/AU2001252482B2/en not_active Expired
- 2001-05-09 EA EA200401056A patent/EA007580B1/ru not_active IP Right Cessation
- 2001-05-09 KR KR10-2002-7015934A patent/KR100523501B1/ko active IP Right Grant
- 2001-05-09 EE EEP200200656A patent/EE05110B1/et active Protection Beyond IP Right Term
- 2001-05-09 DZ DZ013464A patent/DZ3464A1/fr active
- 2001-05-09 AU AU5248201A patent/AU5248201A/xx active Pending
- 2001-05-09 NZ NZ521477A patent/NZ521477A/en not_active IP Right Cessation
- 2001-05-09 DK DK01925808T patent/DK1284974T3/da active
- 2001-05-09 AT AT01925808T patent/ATE260914T1/de active
- 2001-05-09 AP APAP/P/2002/002663A patent/AP1965A/en active
- 2001-05-09 KR KR1020057003492A patent/KR100548854B1/ko active IP Right Grant
- 2001-05-09 GE GEAP2001004960 patent/GEP20063799B/en unknown
- 2001-05-09 EP EP20080163025 patent/EP1990341B1/en not_active Expired - Lifetime
- 2001-05-09 ES ES04004193T patent/ES2311126T3/es not_active Expired - Lifetime
- 2001-05-09 OA OA1200200343A patent/OA12264A/en unknown
- 2001-05-09 PL PL359267A patent/PL200551B1/pl unknown
- 2001-05-09 MX MXPA02011631A patent/MXPA02011631A/es active IP Right Grant
- 2001-05-09 PT PT01925808T patent/PT1284974E/pt unknown
- 2001-05-09 JP JP2001586293A patent/JP3693957B2/ja not_active Expired - Lifetime
- 2001-05-09 CZ CZ20023806A patent/CZ299102B6/cs not_active IP Right Cessation
- 2001-05-09 EA EA200201141A patent/EA005382B1/ru not_active IP Right Cessation
- 2001-05-09 HU HU0302474A patent/HU225810B1/hu active Protection Beyond IP Right Term
- 2001-05-09 CN CNB018088287A patent/CN1279040C/zh not_active Expired - Lifetime
- 2001-05-09 IL IL15253101A patent/IL152531A0/xx unknown
- 2001-05-09 ME MEP-2008-693A patent/ME00555B/me unknown
- 2001-05-09 BR BRPI0110955A patent/BRPI0110955B8/pt not_active IP Right Cessation
- 2001-05-09 EP EP20010925808 patent/EP1284974B1/en not_active Expired - Lifetime
- 2001-05-09 EP EP20040004193 patent/EP1526134B1/en not_active Expired - Lifetime
- 2001-05-09 DE DE60135685T patent/DE60135685D1/de not_active Expired - Lifetime
- 2001-05-09 DK DK04004193T patent/DK1526134T3/da active
- 2001-05-09 SI SI200130090T patent/SI1284974T1/xx unknown
- 2001-05-09 ES ES08163025T patent/ES2401812T3/es not_active Expired - Lifetime
- 2001-05-09 WO PCT/IB2001/000806 patent/WO2001090106A2/en active IP Right Grant
- 2001-05-21 TW TW90112055A patent/TWI230160B/zh active
- 2001-05-22 PA PA8517101A patent/PA8517101A1/es unknown
- 2001-05-22 EG EG20010535A patent/EG24137A/xx active
- 2001-05-23 MY MYPI20012461 patent/MY131019A/en unknown
- 2001-05-23 MY MYPI20041980 patent/MY153023A/en unknown
- 2001-05-23 MY MYPI20094132A patent/MY156920A/en unknown
- 2001-05-24 PE PE2001000476A patent/PE20011371A1/es active IP Right Grant
- 2001-05-24 UY UY26727A patent/UY26727A1/es not_active IP Right Cessation
- 2001-05-24 AR ARP010102486 patent/AR028622A1/es active IP Right Grant
- 2001-05-25 TN TNSN01077 patent/TNSN01077A1/fr unknown
2002
- 2002-09-23 BG BG107140A patent/BG65966B1/bg unknown
- 2002-09-24 IS IS6565A patent/IS2511B/is unknown
- 2002-10-28 CU CU20020243A patent/CU23288B7/es unknown
- 2002-10-28 IL IL152531A patent/IL152531A/en active Protection Beyond IP Right Term
- 2002-10-31 NO NO20025227A patent/NO327892B1/no not_active IP Right Cessation
- 2002-11-14 MA MA26910A patent/MA26902A1/fr unknown
- 2002-11-26 HR HR20020938A patent/HRP20020938B1/xx not_active IP Right Cessation
2003
- 2003-09-30 HK HK03107045A patent/HK1054927A1/xx not_active IP Right Cessation
2005
- 2005-02-15 JP JP2005038062A patent/JP4854970B2/ja not_active Expired - Lifetime
- 2005-11-18 HK HK05110416A patent/HK1078573A1/xx not_active IP Right Cessation
2006
- 2006-10-18 HK HK06111446A patent/HK1090836A1/xx not_active IP Right Cessation
2007
- 2007-03-27 AR ARP070101273 patent/AR060159A2/es unknown
2008
- 2008-02-22 NL NL300338C patent/NL300338I2/nl unknown
- 2008-02-22 LU LU91417C patent/LU91417I2/fr unknown
- 2008-02-25 LT LTPA2008004C patent/LTC1284974I2/lt unknown
- 2008-03-04 FR FR08C0007C patent/FR08C0007I2/fr active Active
- 2008-03-17 CY CY200800006C patent/CY2008006I1/el unknown
- 2008-07-16 CR CR10145A patent/CR10145A/es unknown
- 2008-10-24 CY CY081101203T patent/CY1108451T1/el unknown
2010
- 2010-04-08 NO NO2010007C patent/NO2010007I2/no unknown
2020
- 2020-06-30 NO NO2020019C patent/NO2020019I1/no not_active IP Right Cessation
2022
- 2022-04-19 CY CY2022009C patent/CY2022009I2/el unknown

Also Published As

Publication number	Publication date
GEP20063799B (en)	2006-04-25
CY1108451T1 (el)	2014-04-09
ES2401812T3 (es)	2013-04-24
HK1054927A1 (en)	2003-12-19
FR08C0007I2 (fr)	2009-01-15
RS50904B (sr)	2010-08-31
EE05110B1 (et)	2008-12-15
LU91417I9 (et)	2019-01-02
CY2008006I2 (el)	2009-11-04
JP2005194283A (ja)	2005-07-21
SK16432002A3 (sk)	2004-01-08
EP1526134A2 (en)	2005-04-27
KR100523501B1 (ko)	2005-10-25
NO327892B1 (no)	2009-10-12
NO20025227L (no)	2002-10-31
AR060159A2 (es)	2008-05-28
BG107140A (bg)	2003-05-30
EP1526134A3 (en)	2006-11-29
BG65966B1 (bg)	2010-07-30
NZ521477A (en)	2004-07-30
KR100548854B1 (ko)	2006-02-02
CY2022009I1 (el)	2022-05-27
IS2511B (is)	2009-05-15
LU91417I2 (fr)	2008-04-22
NO2020019I1 (no)	2020-06-30
CN1680371A (zh)	2005-10-12
AP2002002663A0 (en)	2002-12-31
PA8517101A1 (es)	2002-10-24
EG24137A (en)	2008-08-06
IS6565A (is)	2002-09-24
JP3693957B2 (ja)	2005-09-14
WO2001090106A3 (en)	2002-03-28
NO20025227D0 (no)	2002-10-31
EP1990341B1 (en)	2013-01-23
JP4854970B2 (ja)	2012-01-18
SK286129B6 (sk)	2008-04-07
EA007580B1 (ru)	2006-12-29
EP1284974B1 (en)	2004-03-03
ME00555A (en)	2011-12-20
CN1279040C (zh)	2006-10-11
PT1526134E (pt)	2008-10-28
AP1965A (en)	2009-03-04
TR200400541T4 (tr)	2004-04-21
BR0110955A (pt)	2003-06-03
CR10145A (es)	2008-08-19
NL300338I1 (nl)	2008-05-01
OA12264A (en)	2003-11-10
CZ299102B6 (cs)	2008-04-23
AU5248201A (en)	2001-12-03
CA2408909C (en)	2006-06-27
CY2008006I1 (el)	2009-11-04
HUP0302474A2 (hu)	2003-11-28
MY156920A (en)	2016-04-15
EA005382B1 (ru)	2005-02-24
DE60102233T2 (de)	2005-01-27
HU225810B1 (en)	2007-10-29
ME00555B (me)	2011-12-20
PE20011371A1 (es)	2002-01-18
HUP0302474A3 (en)	2007-05-29
EP1990341A1 (en)	2008-11-12
DE122008000011I1 (de)	2008-06-05
DE60102233D1 (de)	2004-04-08
NO2010007I1 (no)	2010-04-08
NL300338I2 (nl)	2008-06-02
ATE260914T1 (de)	2004-03-15
ES2215129T3 (es)	2004-10-01
CA2408909A1 (en)	2001-11-29
DE60135685D1 (de)	2008-10-16
FR08C0007I1 (et)	2008-04-25
LTC1284974I2 (lt)	2020-11-10
IL152531A0 (en)	2003-05-29
AU2001252482B2 (en)	2006-01-19
TWI230160B (en)	2005-04-01
HK1090836A1 (en)	2007-01-05
RS51436B (en)	2011-04-30
ATE407134T1 (de)	2008-09-15
HRP20020938A2 (en)	2005-02-28
CN1437599A (zh)	2003-08-20
BRPI0110955B8 (pt)	2021-05-25
MXPA02011631A (es)	2003-03-27
AU2001252482C1 (en)	2001-12-03
YU82202A (sh)	2005-11-28
UY26727A1 (es)	2001-12-28
CU23288B7 (es)	2008-06-30
MY153023A (en)	2014-12-31
HRP20020938B1 (en)	2011-05-31
JP2003534343A (ja)	2003-11-18
DK1526134T3 (da)	2008-11-17
RS20090438A (en)	2010-05-07
CZ20023806A3 (cs)	2004-01-14
MY131019A (en)	2007-07-31
MA26902A1 (fr)	2004-12-20
DK1284974T3 (da)	2004-06-07
EA200401056A1 (ru)	2005-04-28
TNSN01077A1 (fr)	2005-11-10
WO2001090106A2 (en)	2001-11-29
CY2022009I2 (el)	2022-05-27
HK1078573A1 (en)	2006-03-17
PT1284974E (pt)	2004-06-30
EA200201141A1 (ru)	2003-04-24
ES2311126T3 (es)	2009-02-01
AR028622A1 (es)	2003-05-14
DZ3464A1 (et)	2001-11-29
SI1284974T1 (en)	2004-08-31
LTPA2008004I1 (lt)	2020-07-27
KR20030004417A (ko)	2003-01-14
IL152531A (en)	2010-05-17
SI1526134T1 (sl)	2008-12-31
PL359267A1 (en)	2004-08-23
NO2010007I2 (no)	2013-09-09
EP1526134B1 (en)	2008-09-03
KR20050046743A (ko)	2005-05-18
EP1284974A2 (en)	2003-02-26
PL200551B1 (pl)	2009-01-30
CN100355753C (zh)	2007-12-19
BRPI0110955B1 (pt)	2016-06-28

Publication	Publication Date	Title
EE200200656A (et)	2004-06-15	Ravis kasutatavad tropaani derivaadid
NO20021400D0 (no)	2002-03-20	Terapeutiske konazolinderivater
NO20032909D0 (no)	2003-06-24	Glukopyranosyloksypyrazolderivater samt medikamentell anvendelse derav
DK1637127T3 (da)	2014-08-04	Terapeutisk mikroskum
ATE540013T1 (de)	2012-01-15	Naphthalinderivate
DK1292604T3 (da)	2009-06-15	2-Aminocarbonyl-9H-purinderivater
NO20021329D0 (no)	2002-03-18	Kinaseinhibitorer som terapeutiske midler
NO20033203L (no)	2003-09-02	Terapeutiske heterocykliske forbindelser
PT1235558E (pt)	2006-09-29	Agentes terapeuticos
ATE298332T1 (de)	2005-07-15	Decahydro-isochinolinderivate
GB0013383D0 (en)	2000-07-26	Therapeutic benzamide derivatives
DK1280809T3 (da)	2005-11-07	Antitumorecteinascidinderivater
ATE414056T1 (de)	2008-11-15	Substituierte c-cyclohexylmethylamin-derivative
GB0013346D0 (en)	2000-07-26	Therapeutic benzamide derivatives
DK1322593T3 (da)	2004-10-11	O-substituerede-6-methyl-tramadol-derivater
GB0026578D0 (en)	2000-12-13	Heterocyclic derivatives useful as pharmaceutical agents
ATE282021T1 (de)	2004-11-15	Substituierte aminomethyl-phenyl- cyclohexanderivate
DK1246791T3 (da)	2005-02-14	Aminomethyl-phenyl-cyklohexanonderivater
NO20030547L (no)	2003-02-04	Azabicykliske derivater og deres terapeutiske anvendelse
DE60015576D1 (de)	2004-12-09	4-fluoroalkyl-3-halophenyl nortropane
NO20016301D0 (no)	2001-12-21	Terapeutiske midler
DZ3364A1 (fr)	2002-02-07	Agent therapeutique cristallin
ATE361274T1 (de)	2007-05-15	Substituierte 5-amino-1-penten-3-ol-derivate
ATE374776T1 (de)	2007-10-15	Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no)	2002-09-13	2-fenylpyran-4-on-derivater

Legal Events

Date	Code	Title	Description
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2009-08-17	AA1Y	Spc filed	Free format text: PRODUCT NAME: CELSENTRI-MARAVIROC Spc suppl protection certif: C20090002 Filing date: 20090529
2009-10-15	FG1Y	Spc granted	Free format text: PRODUCT NAME: CELSENTRI-MARAVIROC Spc suppl protection certif: C20090002 00023 Filing date: 20090529 Extension date: 20220918
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2015-11-16	HC1A	Change of owner name
2016-10-17	SPCM	Correction and amendment to the data concerning application for a supplementary protection certificate	Spc suppl protection certif: C20090002 00023 Extension date: 20220920
2020-03-16	GB1A	Change in the ownership or in the address of the owner
2021-02-15	SPCZ	Extension of supplementary protection certificate: granted [paediatric extension]	Free format text: PRODUCT NAME: MARAVIROC; NATIONAL AUTHORISATION NUMBER: EMA/253407/2017; DATE OF AUTHORISATION: 20170421 Spc suppl protection certif: C20090002 Extension date: 20230318